Literature DB >> 11263501

Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

R K Gupta1, T F Cloughesy, U Sinha, J Garakian, J Lazareff, G Rubino, L Rubino, D P Becker, H V Vinters, J R Alger.   

Abstract

This study sought to correlate quantitative presurgical proton magnetic resonance spectroscopic imaging (1H-MRSI) and diffusion imaging (DI) results with quantitative histopathological features of resected glioma tissue. The primary hypotheses were (1) glioma choline signal correlates with cell density, (2) glioma apparent diffusion coefficient (ADC) correlates inversely with cell density, (3) glioma choline signal correlates with cell proliferative index. Eighteen adult glioma patients were preoperatively imaged with 1H-MRSI and DI as part of clinically-indicated MRI evaluations. Cell density and proliferative index readings were made on surgical specimens obtained at surgery performed within 12 days of the radiologic scans. The resected tissue location was identified by comparing preoperative and postoperative MRI. The tumor to contralateral normalized choline signal ratio (nCho) and the ADC from resected tumor regions were measured from the preoperative imaging data. Counts of nuclei per high power field in 5-10 fields provided a quantitative measure of cell density. MIB-1 immunohistochemistry provided an index of the proportion of proliferating cells. There was a statistically significant inverse linear correlation between glioma ADC and cell density. There was also a statistically significant linear correlation between the glioma nCho and the cell density. The nCho measure did not significantly correlate with proliferative index. The results indicate that both ADC and spectroscopic choline measures are related to glioma cell density. Therefore they may prove useful for differentiating dense cellular neoplastic lesions from those that contain large proportions of acellular necrotic space.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11263501     DOI: 10.1023/a:1006431120031

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas.

Authors:  J A Lazareff; C Olmstead; K H Bockhorst; J R Alger
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

2.  MR diffusion imaging of human intracranial tumours.

Authors:  K Krabbe; P Gideon; P Wagn; U Hansen; C Thomsen; F Madsen
Journal:  Neuroradiology       Date:  1997-07       Impact factor: 2.804

Review 3.  Diffusion and perfusion magnetic resonance imaging in brain tumors.

Authors:  D Le Bihan; P Douek; M Argyropoulou; R Turner; N Patronas; M Fulham
Journal:  Top Magn Reson Imaging       Date:  1993

4.  Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours.

Authors:  C M Carapella; G Carpinelli; A Knijn; L Raus; F Caroli; F Podo
Journal:  Acta Neurochir Suppl       Date:  1997

5.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma.

Authors:  R K Gupta; U Sinha; T F Cloughesy; J R Alger
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

6.  Apoptosis and cell proliferation in human neuroepithelial tumors.

Authors:  D Schiffer; P Cavalla; A Migheli; A Chiò; M T Giordana; S Marino; A Attanasio
Journal:  Neurosci Lett       Date:  1995-08-04       Impact factor: 3.046

7.  Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

Authors:  S W Coons; P C Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

8.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

9.  Human brain tumors: assessment with in vivo proton MR spectroscopy.

Authors:  D Ott; J Hennig; T Ernst
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

10.  Multisection proton MR spectroscopic imaging of the brain.

Authors:  J H Duyn; J Gillen; G Sobering; P C van Zijl; C T Moonen
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

View more
  101 in total

1.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Authors:  Radhika Srinivasan; Joanna J Phillips; Scott R Vandenberg; Mei-Yin C Polley; Gabriela Bourne; Alvin Au; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-07-20       Impact factor: 12.300

2.  Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.

Authors:  Guido H Jajamovich; Chandni R Valiathan; Razvan Cristescu; Sangeetha Somayajula
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

3.  MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.

Authors:  Chih-Chun Wu; Rajan Jain; Lucidio Neto; Seema Patel; Laila M Poisson; Jonathan Serrano; Victor Ng; Sohil H Patel; Dimitris G Placantonakis; David Zagzag; John Golfinos; Andrew S Chi; Matija Snuderl
Journal:  Neuroradiology       Date:  2019-05-27       Impact factor: 2.804

Review 4.  Extracranial applications of diffusion-weighted magnetic resonance imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

5.  Diffusion imaging for tumor grading of supratentorial brain tumors in the first year of life.

Authors:  S F Kralik; A Taha; A P Kamer; J S Cardinal; T A Seltman; C Y Ho
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-07       Impact factor: 3.825

6.  Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Authors:  Kai Zhang; Chuanfu Li; Ying Liu; Li Li; Xiangxing Ma; Xiangshui Meng; Dechao Feng
Journal:  Neuroradiology       Date:  2007-09-01       Impact factor: 2.804

7.  Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation.

Authors:  Jelena Lazovic; Horacio Soto; David Piccioni; Jerry R Lou; Sichen Li; Leili Mirsadraei; William Yong; Robert Prins; Linda M Liau; Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

8.  The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.

Authors:  Dita Wagnerova; Filip Jiru; Monika Dezortova; Lydie Vargova; Eva Sykova; Milan Hajek
Journal:  MAGMA       Date:  2008-10-25       Impact factor: 2.310

9.  Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Authors:  S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

10.  Relationship between choline and apparent diffusion coefficient in patients with gliomas.

Authors:  Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.